Urist Marshall 4
4 · Royalty Pharma plc · Filed May 9, 2025
Insider Transaction Report
Form 4
Urist Marshall
EVP, Research & Investments
Transactions
- Award
Class A Ordinary Shares
2025-05-08+36,484→ 83,151 total
Holdings
- 19,020(indirect: By IRA)
Class A Ordinary Shares
Footnotes (1)
- [F1]Reflects the exempt acquisition by the Reporting Person pursuant to Rule 16b-3 of Class A Ordinary Shares of the Issuer in connection with the settlement of Equity Performance Awards.